RACHEL STONE: Open Payments
NPI 1457800682 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$573 in 31 payments from 14 companies in 2025. Trend: 2023 $55 · 2024 $525 · 2025 $573
Food & beverage: $573
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $157 |
| AstraZeneca Pharmaceuticals LP | 4 | $83 |
| ABBVIE INC. | 2 | $42 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $38 |
| IBSA Pharma Inc. | 2 | $38 |
| Exact Sciences Corporation | 2 | $38 |
| Edwards Lifesciences Corporation | 1 | $29 |
| Azurity Pharmaceuticals, Inc. | 2 | $27 |
| Sumitomo Pharma America, Inc. | 1 | $26 |
| Abbott Laboratories | 1 | $25 |
Products named: Ozempic, Wegovy, BREZTRI, Tirosint, CAPLYTA, Cologuard Collection Kit, EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV), FARXIGA.
Industry payments across NC — which companies pay providers there.
